PaoloFantiMD
Nephrology • San Antonio, TXAssociate Professor, Medicine, University of Texas Medical School, San Antonio
Are you Dr. Fanti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 36 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4502 Medical Dr
San Antonio, TX 78229Phone+1 210-257-1400- Is this information wrong?
Summary
- Dr. Paolo Fanti, MD is a nephrologist in San Antonio, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Audie L. Murphy Memorial Veterans' Hospital and University Health / UT Health Science Center at San Antonio.
Education & Training
University of Kentucky College of MedicineFellowship, Nephrology, 1991 - 1992- University of Kentucky College of MedicineResidency, Internal Medicine, 1983 - 1991
University of BolognaClass of 1979
Certifications & Licensure
TX State Medical License 2007 - 2025
Clinical Trials
- Soy Protein in Early Diabetic Nephropathy Start of enrollment: 2001 Jul 01
- N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy Start of enrollment: 2009 Oct 01
- N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- Spleen contributes significantly to increased circulating levels of fibroblast growth factor23 in response to lipopolysaccharide-induced inflammation.Shweta Bansal, William E Friedrichs, Chakradhar Velagapudi, Denis Feliers, Khaled Khazim, Diane Horn, John E Cornell, Sherry L Werner, Paolo Fanti> ;Nephrology, Dialysis, Transplantation. 2017 Mar 1
- 10 citationsSpleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.Shweta Bansal, William E Friedrichs, Chakradhar Velagapudi, Denis Feliers, Khaled Khazim, Diane Horn, John E Cornell, Sherry L Werner, Paolo Fanti> ;Nephrology, Dialysis, Transplantation. 2017 Jun 1
- 4 citationsErgocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patientsGaurav Agarwal, Padam Hirachan, Jonathan Gelfond, Paolo Fanti, Claudia Hura, Shweta Bansal> ;BMC Nephrology. 2016 Oct 7
- Join now to see all
Grant Support
- Correction Of Glutathione Deficiency For Treatment Of Diabetic NephropathyVeterans Affairs2011–2012
- N-Acetylcysteine And Milk Thistle For Treatment Of Diabetic NephropathyNational Center For Complementary &Alternative Medicine2009–2011
- PK Of Silybin-Phosphatidylcholine Complex (SILIPHOS) In Diabetic NephropathyNational Center For Research Resources2006–2007
- Isoflavones:Acute Response In Chronic Renal FailureNational Center For Complementary &Alternative Medicine2001–2002
- Soy Protein Use In Early Diabetic NephropathyNational Center For Complementary &Alternative Medicine2000–2001
- Soybean &Urine Lithogenicity In Recurrent Calcium Oxalate NephropathyNational Center For Research Resources1999–2000
- Soybean &Urine Lithogenicity In Recurrent Calcium Oxalate NephrolithiasisNational Center For Research Resources1998
Hospital Affiliations
University Health / UT Health Science Center at San AntonioSan Antonio, Texas
Audie L. Murphy Memorial Veterans' HospitalSan Antonio, Texas
